Skip to main content
Year archive

ANAGENICS LIMITED — 2018 filings

All 66 regulatory filings released by ANAGENICS LIMITED (AN1) in 2018, sourced directly from the official regulator.

66 Filings
2018 Period
2018 filings (66)
Filing Released Lang
Cellmid Expects Record Sales in Q2 FY2019 2 pages 222.5KB
Regulatory Filings
2018-12-11 English
Cellmid Appoints Exclusive New Zealand Distributor 2 pages 223.1KB
Regulatory Filings
2018-11-18 English
Change of Director's Interest Notice - Eck 2 pages 346.6KB
Regulatory Filings
2018-11-12 English
Change of Director's Interest Notice - Halasz 3 pages 352.6KB
Regulatory Filings
2018-11-12 English
Appendix 3B and Cleansing Notice 14 pages 922.9KB
Regulatory Filings
2018-11-11 English
AGM Presentation to Shareholders 18 pages 1.9MB
Regulatory Filings
2018-11-07 English
Results of Annual General Meeting 3 pages 411.1KB
Regulatory Filings
2018-11-07 English
New Patents for Midkine Antibodies in USA and Europe 2 pages 226.0KB
Regulatory Filings
2018-11-06 English
Trading Halt 2 pages 149.4KB
Regulatory Filings
2018-11-01 English
Ikon Legal Action - Decision 1 page 200.3KB
Regulatory Filings
2018-11-01 English
Repayment of R&D Loan 2 pages 207.1KB
Regulatory Filings
2018-10-31 English
Cellmid's Evolis Successfully Launched in USA stores 3 pages 226.8KB
Regulatory Filings
2018-10-31 English
Investor Presentation 30 pages 2.4MB
Regulatory Filings
2018-10-30 English
Cellmid receives R&D tax credit 1 page 61.1KB
Regulatory Filings
2018-10-29 English
Appendix 4C and Notes to Appendix 4C 9 pages 491.7KB
Regulatory Filings
2018-10-14 English
Notice of Annual General Meeting/Proxy Form 20 pages 1.3MB
Regulatory Filings
2018-10-08 English
Appendix 3B and Cleansing Notice 14 pages 910.6KB
Regulatory Filings
2018-10-07 English
Appendix 3B 13 pages 843.3KB
Regulatory Filings
2018-10-02 English
Cleansing Notice 1 page 197.8KB
Regulatory Filings
2018-10-02 English
Appendix 3B 13 pages 898.9KB
Regulatory Filings
2018-09-27 English
Annual Report to shareholders 72 pages 2.4MB
Regulatory Filings
2018-09-26 English
Appendix 4G and Corporate Governance Statement 23 pages 542.6KB
Regulatory Filings
2018-09-26 English
Change of Director's Interest Notice - Gordon 2 pages 248.6KB
Regulatory Filings
2018-09-24 English
Clarification Announcement 2 pages 77.5KB
Regulatory Filings
2018-09-23 English
CDY Investor Newsletter - 21 September 2018 6 pages 514.7KB
Regulatory Filings
2018-09-20 English
Full Year Statutory Accounts 61 pages 441.7KB
Regulatory Filings
2018-09-18 English
Date of Annual General Meeting 1 page 71.8KB
Regulatory Filings
2018-09-18 English
Becoming a substantial holder 2 pages 194.5KB
Regulatory Filings
2018-09-13 English
Change of Director's Interest Notice-Halasz 2 pages 347.5KB
Regulatory Filings
2018-09-12 English
Change of Director's Interest Notice-Gordon 2 pages 248.9KB
Regulatory Filings
2018-09-12 English
Change of Director's Interest Notice-Eck 2 pages 248.2KB
Regulatory Filings
2018-09-12 English
Change of Director's Interest Notice-Cross 2 pages 248.7KB
Regulatory Filings
2018-09-12 English
Lead Antibody Effective in Rare Chronic Kidney Disease 3 pages 33.7KB
Regulatory Filings
2018-09-11 English
Appendix 3B 13 pages 845.9KB
Regulatory Filings
2018-09-11 English
Cleansing Notice 1 page 197.9KB
Regulatory Filings
2018-09-11 English
EGM Presentation by CEO 27 pages 3.3MB
Regulatory Filings
2018-09-06 English
Results of Meeting 2 pages 408.4KB
Regulatory Filings
2018-09-06 English
Company Secretary Appointment/Resignation 1 page 19
Regulatory Filings
2018-09-05 English
Cellmid Share Purchase Plan Completion 2 pages 134.5KB
Regulatory Filings
2018-09-02 English
Evolis USA Distribution Update 3 pages 115.0KB
Regulatory Filings
2018-08-29 English
Preliminary Final Report 19 pages 224.3KB
Regulatory Filings
2018-08-23 English
Cleansing Notice and Appendix 3B 12 pages 397.7KB
Regulatory Filings
2018-08-05 English
Cellmid Notice of Meeting 11 pages 135.5KB
Regulatory Filings
2018-08-05 English
Appendix 4C and Notes to Appendix 4C 9 pages 307.9KB
Regulatory Filings
2018-07-30 English
Cellmid Share Placement Raises $9M 3 pages 101.7KB
Regulatory Filings
2018-07-30 English
Cellmid Share Purchase Plan 5 pages 154.3KB
Regulatory Filings
2018-07-30 English
Trading Halt 2 pages 146.3KB
Regulatory Filings
2018-07-26 English
CELLMID UPDATES ON DISTRIBUTION OF EVOLIS 3 pages 176.5KB
Regulatory Filings
2018-07-10 English
CELLMID INVESTOR PRESENTATION 30 pages 2.5MB
Regulatory Filings
2018-07-01 English
MIDKINE SYMPOSIUM MUNICH 3 pages 296.3KB
Regulatory Filings
2018-05-29 English
CHANGE OF ADDRESS 2 pages 151.5KB
Regulatory Filings
2018-05-28 English
CELLMID TO COMMENCE SELLING OF EVOLIS INTO CHINESE MARKET 3 pages 181.7KB
Regulatory Filings
2018-05-01 English
CELLMID SECURES BLOOMINGDALES USA PARTNERSHIP FOR EVOLIS 2 pages 87.7KB
Regulatory Filings
2018-04-23 English
Appendix 4C - quarterly 8 pages 119.0KB
Regulatory Filings
2018-04-22 English
Cellmid Investor Presentation 31 pages 2.6MB
Regulatory Filings
2018-04-09 English
CELLMID CONVENING 5TH MIDKINE SYMPOSIUM IN MUNICH 3 pages 96.1KB
Regulatory Filings
2018-04-08 English
CELLMID SIGNS DISTRIBUTION AGREEMENT FOR FILLERINA 2 pages 321.3KB
Regulatory Filings
2018-04-03 English
Change of Director's Interest Notice-Halasz 3 pages 280.0KB
Regulatory Filings
2018-03-28 English
CELLMID APPOINTS DENNIS ECK NON-EXECUTIVE DIRECTOR 2 pages 26.9KB
Regulatory Filings
2018-03-25 English
Initial Director's Interest Notice 2 pages 11.2KB
Regulatory Filings
2018-03-25 English
Change of Director's Interest Notice-Halasz 3 pages 223.2KB
Regulatory Filings
2018-03-13 English
Appendix 4D and Half Year Accounts 27 pages 217.7KB
Regulatory Filings
2018-02-21 English
Change of Director's Interest Notice-Halasz 3 pages 223.1KB
Regulatory Filings
2018-01-30 English
Appendix 4C - quarterly 6 pages 238.8KB
Regulatory Filings
2018-01-24 English
RECORD 2M SALES FOR CELLMID FGF5 INHIBITORS 1 page
Regulatory Filings
2018-01-09 English
CELLMID QUARTERLY OPERATIONAL UPDATE 3 pages 89.2KB
Regulatory Filings
2018-01-08 English